Federated Hermes
THRD

Federated Hermes’s Third Harmonic Bio THRD Stock Holding History

Federated Hermes’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,168
Closed -$11K – 2185
2025
Q1 		$11K Buy
+3,168
New +$15.4K ﹤0.01% 1794
2024
Q4 		– Sell
-661
Closed -$8.96K – 2188
2024
Q3 		$8.96K Sell
661
-227
-26% -$2.81K ﹤0.01% 1817
2024
Q2 		$11.5K Buy
888
+49
+6% +$606 ﹤0.01% 1767
2024
Q1 		$7.92K Hold
839
– – ﹤0.01% 1801
2023
Q4 		$9.2K Buy
+839
New +$6.65K ﹤0.01% 1797

Other funds holding THRD

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Federated Hermes's THRD Position: Q2 2025 in Review

Federated Hermes sold out of Third Harmonic Bio (THRD) in Q2 2025, closing a stake of 3,168 shares — an estimated $11K sold.

Federated Hermes first reported a position in THRD in Q4 2023 and held it in 5 quarters. The position peaked at $11.5K in Q2 2024. 105 funds tracked by Wall St. Rank hold THRD as of Q2 2025.

  • Federated Hermes reported no remaining Third Harmonic Bio position as of Q2 2025 after selling out during the quarter.
  • Federated Hermes sold 3,168 Third Harmonic Bio shares in Q2 2025, an estimated $11K.
  • Federated Hermes first reported a position in Third Harmonic Bio in Q4 2023 and held it in 5 quarters.
  • Federated Hermes's Third Harmonic Bio position peaked at $11.5K in Q2 2024.
  • 105 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q2 2025.

Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.